Vaccine Effectiveness Research Thanks to our generous donors and our established partnership with the Ministry of Health, we were able to rapidly fund novel and real-time vaccine effectiveness research led by Dr Danuta Skowronski, who is studying COVID-19 vaccine effectiveness, which looks at strength, durability, and interchangeability (protection offered when mixing vaccines). This ongoing work, which began in early 2021, soon after the 昀椀rst mRNA vaccines came on the scene, is providing invaluable insights that have not only bene昀椀tted British Columbians, but informed crucial decisions and responses around the world. We’re deeply grateful to The Mathisen Family Private Foundation whose philanthropy is grounded in innovative and transformative projects like vaccine effectiveness research: “Our Foundation is proud to continue a long tradition of A.K. and B.M. Mathisen’s support for the communities we call home. We understand the need and importance of helping to support the advancement of healthcare and research, which is why we chose to support the critical vaccine effectiveness research project—which supported vital pandemic recovery efforts—keeping our communities safe from COVID and respiratory illness.” -The Mathisen Family Private Foundation We remain humbled by the generosity of all of our donors, and especially grateful to those like Paci昀椀c Blue Cross Health Foundation and The Mathisen Family Private Foundation for their exceptional gifts that promote health equity, and are making a big impact on the health of British Columbians of all ages. 19 2022-23 ANNUAL REPORT